We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHC
1076
Diversified Healthcare Trust
DHC
$2.13B
| $6.76M | 0.01% |
801,532
+20,928
| +3% | +$176K |
|
|
GWB
1077
DELISTED
Great Western Bancorp, Inc.
GWB
| $6.7M | 0.01% |
192,966
+11,367
| +6% | +$393K |
|
|
MNTA
1078
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $6.7M | 0.01% |
339,340
+42,580
| +14% | +$681K |
|
|
HZNP
1079
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.7M | 0.01% |
184,955
+3,498
| +2% | +$107K |
|
1080
FormFactor
FORM
$9.38B
| $6.67M | 0.01% |
256,739
+14,828
| +6% | +$334K |
|
|
PPBI
1081
DELISTED
Pacific Premier Bancorp
PPBI
| $6.65M | 0.01% |
204,023
+12,159
| +6% | +$396K |
|
1082
Jack in the Box
JACK
$329M
| $6.64M | 0.01% |
85,144
-3,097
| -4% | -$256K |
|
1083
Sensata Technologies
ST
$7.08B
| $6.64M | 0.01% |
123,186
+1,435
| +1% | +$73.7K |
|
|
HDS
1084
DELISTED
HD Supply Holdings, Inc.
HDS
| $6.63M | 0.01% |
164,958
+198
| +0.1% | +$7.87K |
|
|
NSA
1085
DELISTED
National Storage Affiliates Trust
NSA
| $6.63M | 0.01% |
197,192
+16,117
| +9% | +$540K |
|
|
PRA
1086
DELISTED
ProAssurance
PRA
| $6.62M | 0.01% |
183,102
+9,555
| +6% | +$366K |
|
1087
EQT Corp
EQT
$33B
| $6.61M | 0.01% |
606,529
+1,196
| +0.2% | +$11.7K |
|
1088
Graham Holdings Company
GHC
$5.13B
| $6.59M | 0.01% |
10,312
+2
| +0% | +$1.28K |
|
1089
Aaon
AAON
$7.83B
| $6.58M | 0.01% |
199,712
+9,791
| +5% | +$317K |
|
1090
Global Net Lease
GNL
$1.81B
| $6.57M | 0.01% |
323,699
+35,968
| +13% | +$709K |
|
|
IBKC
1091
DELISTED
IBERIABANK Corp
IBKC
| $6.57M | 0.01% |
87,728
+2,987
| +4% | +$222K |
|
|
GBT
1092
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $6.55M | 0.01% |
82,344
+3,924
| +5% | +$233K |
|
1093
Ligand Pharmaceuticals
LGND
$6.03B
| $6.54M | 0.01% |
100,548
-4,899
| -5% | -$327K |
|
|
ETRN
1094
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $6.54M | 0.01% |
489,497
-29,464
| -6% | -$366K |
|
|
CVSA
1095
Covista Inc
CVSA
$4.42B
| $6.54M | 0.01% |
186,930
-3,576
| -2% | -$123K |
|
1096
Group 1 Automotive
GPI
$3.41B
| $6.53M | 0.01% |
65,284
+3,787
| +6% | +$374K |
|
1097
Four Corners Property Trust
FCPT
$2.76B
| $6.52M | 0.01% |
231,339
+16,541
| +8% | +$463K |
|
1098
Kinsale Capital Group
KNSL
$8.26B
| $6.52M | 0.01% |
64,147
+37,798
| +143% | +$3.76M |
|
|
KAMN
1099
DELISTED
Kaman Corp
KAMN
| $6.51M | 0.01% |
98,781
+5,894
| +6% | +$368K |
|
1100
Winnebago Industries
WGO
$901M
| $6.51M | 0.01% |
122,832
+12,463
| +11% | +$583K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.